Bioluminescence methodology for the detection of protein-protein interactions within the voltage-gated sodium channel macromolecular complex

Assay and Drug Development Technologies

Volumn 10, Issue 2, 2012, Pages 148-160

  Shavkunov, Alexander ^a   Panova, Neli ^a   Prasai, Anesh ^a   Veselenak, Ron ^b,c   Bourne, Nigel ^b,c   Stoilova McPhie, Svetla ^a   Laezza, Fernanda ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c Galveston National Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CD4 ANTIGEN; FIBROBLAST GROWTH FACTOR 14; LEUCINE; VOLTAGE GATED SODIUM CHANNEL;

AMINO TERMINAL SEQUENCE; ARTICLE; BIOLUMINESCENCE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG MECHANISM; MACROMOLECULE; PROTEIN ASSEMBLY; PROTEIN DETERMINATION; PROTEIN PROTEIN INTERACTION;

ALGORITHMS; AMINO ACIDS; ANIMALS; BLOTTING, WESTERN; CELL SURVIVAL; DNA; FIBROBLAST GROWTH FACTORS; FIREFLIES; GENETIC COMPLEMENTATION TEST; GENETIC VECTORS; HEK293 CELLS; HUMANS; INDICATORS AND REAGENTS; ION CHANNEL GATING; LUCIFERASES; LUMINESCENCE; LUMINESCENT PROTEINS; MODELS, MOLECULAR; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; SODIUM CHANNELS;

EID: 84859876802     PISSN: 1540658X     EISSN: 15578127     Source Type: Journal    
DOI: 10.1089/adt.2011.413     Document Type: Article

References (84)

1. Thayer DA, Jan LY: Mechanisms of distribution and targeting of neuronal ion channels. Curr Opin Drug Discov Devel 2010;13:559-567
2. Leterrier C, Brachet A, Fache MP, Dargent B: Voltage-gated sodium channel organization in neurons: protein interactions and trafficking pathways. Neurosci Lett 2010: 486:92-100
3. Catterall WA: Signaling complexes of voltage-gated sodium and calcium channels. Neurosci Lett 2010;486:107-116
4. Berg T: Small-molecule inhibitors of protein-protein interactions. Curr Opin Drug Discov Devel 2008;11:666-674
5. Acuner Ozbabacan SE, Gursoy A, Keskin O, Nussinov R: Conformational ensembles, signal transduction and residue hot spots: application to drug discovery. Curr Opin Drug Discov Devel 2010;13:527-537
6. Catterall WA, Goldin AL, Waxman SG: International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev 2005;57:397-409
7. Smallwood PM, Munoz-Sanjuan I, Tong P, et al.: Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. Proc Natl Acad Sci USA 1996;93:9850-9857
8. Laezza F, Lampert A, Kozel MA, et al.: FGF14 N-terminal splice variants differentially modulate Nav1.2 and Nav1.6-encoded sodium channels. Mol Cell Neurosci 2009;42:90-101
9. Goetz R, Dover K, Laezza F, et al.: Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. J Biol Chem 2009;284: 17883-17896
10. Laezza F, Gerber BR, Lou JY, et al.: The FGF14(F145S) mutation disrupts the interaction of FGF14 with voltage-gated Na + channels and impairs neuronal excitability. J Neurosci 2007;27:12033-12044
11. Lou JY, Laezza F, Gerber BR, et al.: Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels. J Physiol 2005;569:179-193
12. Goldfarb M, Schoorlemmer J, Williams A, et al.: Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels. Neuron 2007;55:449-463
13. Dover K, Solinas S, D'Angelo E, Goldfarb M: Long-term inactivation particle for voltage-gated sodium channels. J Physiol 2010;588:3695-3711
14. Rush AM, Wittmack EK, Tyrrell L, et al.: Differential modulation of sodium channel Na(v)1.6 by two members of the fibroblast growth factor homologous factor 2 subfamily. Eur J Neurosci 2006;23:2551-2562
15. Wittmack EK, Rush AM, Craner MJ, Goldfarb M, Waxman SG, Dib-Hajj SD: Fibroblast growth factor homologous factor 2B: association with Nav1.6 and selective colocalization at nodes of ranvier of dorsal root axons. J Neurosci 2004;24:6765-6775
16. Liu CJ, Dib-Hajj SD, Renganathan M, Cummins TR, Waxman SG: Modulation of the cardiac sodium channel Na(v)1.5 by fibroblast growth factor homologous factor 1B. J Biol Chem 2003;278:1029-1036
17. Liu C, Dib-Hajj SD, Waxman SG: Fibroblast growth factor homologous factor 1B binds to the C terminus of the tetrodotoxin-resistant sodium channel rNav1.9a (NaN). J Biol Chem 2001;276:18925-18933
18. Cusdin FS, Clare JJ, Jackson AP: Trafficking and cellular distribution of voltagegated sodium channels. Traffic 2008;9:17-26
19. Wang C, Wang C, Hoch EG, Pitt GS: Identification of novel interaction sites that determine specificity between fibroblast growth factor homologous factors and voltage gated sodium channels. J Biol Chem 2011;286:2453-2463
20. Brusse E, de Koning I, Maat-Kievit A, Oostra BA, Heutink P, van Swieten JC: Spinocerebellar ataxia associated with a mutation in the fibroblast growth factor 14 gene (SCA27): a new phenotype. Mov Disord 2006;21: 396-401
21. Van Swieten JC, Brusse E, de Graaf BM, et al.: A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia. Am J Hum Genet 2003;72:191-199
22. Shakkottai VG, Xiao M, Xu L, et al.: FGF14 regulates the intrinsic excitability of cerebellar Purkinje neurons. Neurobiol Dis 2009;33:81-88
23. Xiao M, Xu L, Laezza F, Yamada K, Feng S, Ornitz DM: Impaired hippocampal synaptic transmission and plasticity in mice lacking fibroblast growth factor 14. Mol Cell Neurosci 2007;34:366-377
24. Kiss L, Bennett PB, Uebele VN, et al.: High throughput ion-channel pharmacology: planar-array-based voltage clamp. Assay Drug Dev Technol2003;1:127-135
25. Masi A, Cicchi R, Carloni A, Pavone FS, Arcangeli A: Optical methods in the study of protein-protein interactions. Adv Exp Med Biol 2010;674:33-42
26. Terstappen GC: Nonradioactive rubidium ion efflux assay and its applications in drug discovery and development. Assay Drug Dev Technol 2004;2:553-559
27. Michnick SW, Ear PH, Manderson EN, Remy I, Stefan E: Universal strategies in research and drug discovery based on protein-fragment complementation assays. Nat Rev Drug Discov 2007;6:569-582
28. Johnsson N, Varshavsky A: Split ubiquitin as a sensor of protein interactions in vivo. Proc Natl Acad Sci USA 1994;91:10340-10344
29. Pelletier JN, Campbell-Valois FX, Michnick SW: Oligomerization domain-directed reassembly of active dihydrofolate reductase from rationally designed fragments. Proc Natl Acad Sci USA 1998;95:12141-12146
30. Galarneau A, Primeau M, Trudeau LE, Michnick SW: Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein protein interactions. Nat Biotechnol 2002;20:619-622
31. Magliery TJ, Wilson CG, Pan W, et al.: Detecting protein-protein interactions with a green fluorescent protein fragment reassembly trap: scope and mechanism. J Am Chem Soc 2005;127:146-157
32. Hu CD, Kerppola TK: Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat Biotechnol 2003;21:539-545
33. Stefan E, Aquin S, Berger N, et al.: Quantification of dynamic protein complexes using Renilla luciferase fragment complementation applied to protein kinase A activities in vivo. Proc Natl Acad Sci USA 2007;104:16916-16921
34. Remy I, Michnick SW: A highly sensitive protein-protein interaction assay based on Gaussia luciferase. Nat Methods 2006;3:977-979
35. Luker KE, Smith MC, Luker GD, Gammon ST, Piwnica-Worms H, Piwnica-Worms D: Kinetics of regulated protein-protein interactions revealed with firefly luciferase complementation imaging in cells and living animals. Proc Natl Acad Sci USA 2004;101:12288-12293
36. Rowe L, Dikici E, Daunert S: Engineering bioluminescent proteins: expanding their analytical potential. Anal Chem 2009;81:8662-8668
37. Inglese J, Johnson RL, Simeonov A, et al.: High-throughput screening assays for the identification of chemical probes. Nat Chem Biol 2007;3:466-79
38. Garrido JJ, Fernandes F, Giraud P, et al.: Identification of an axonal determinant in the C-terminus of the sodium channel Na(v)1.2. EMBO J 2001;20:5950-5961
39. Garrido JJ, Giraud P, Carlier E, et al.: A targeting motif involved in sodium channel clustering at the axonal initial segment. Science 2003;300:2091-2094
40. Garrido JJ, Fernandes F, Moussif A, Fache MP, Giraud P, Dargent B: Dynamic compartmentalization of the voltage-gated sodium channels in axons. Biol Cell 2003;95:437-45
41. Pettersen EF, Goddard TD, Huang CC, et al.: UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 2004;25:1605-1612
42. Lovell S, Word JM, Richardson JS, Richardson DC: The penultimate rotamer library. Proteins 2000;40:389-408
43. Gregersen N, Bolund L, Bross P: Protein misfolding, aggregation, and degradation in disease. Methods Mol Biol 2003;232:3-16
44. Berendt FJ, Park KS, Trimmer JS: Multisite phosphorylation of voltage-gated sodium channel alpha subunits from rat brain. J Proteome Res 2010;9:1976-1984
45. Bréchet A, Fache MP, Brachet A, et al.: Protein kinase CK2 contributes to the organization of sodium channels in axonal membranes by regulating their interactions with ankyrin G. J Cell Biol 2008;183:1101-1114
46. Schoorlemmer J, Goldfarb M: Fibroblast growth factor homologous factors and the islet brain-2 scaffold protein regulate activation of a stress-activated protein kinase. J Biol Chem 2002;277:49111-49119
47. Shao D, Okuse K, Djamgoz MB: Protein-protein interactions involving voltagegated sodium channels: post-translational regulation, intracellular trafficking and functional expression. Int J Biochem Cell Biol 2009;41:1471-1481
48. Schultz C, König HG, Del Turco D, et al.: Coincident enrichment of phosphorylated IkappaBalpha, activated IKK, and phosphorylated p65 in the axon initial segment of neurons. Mol Cell Neurosci 2006;33:68-80
49. Sweatt JD: The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 2001;76:1-10
50. Thorne N, Auld DS, Inglese J: Apparent activity in high-throughput screening: origins of compound-dependent assay interference. Curr Opin Chem Biol 2010;14:315-324
51. Herbst KJ, Allen MD, Zhang J: The cAMP-dependent protein kinase inhibitor H- 89 attenuates the bioluminescence signal produced by Renilla Luciferase. PLoS One 2009;4:e5642
52. Pierce J, Schoenleber R, Jesmok G, et al.: Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997;272:21096-21103
53. Fu Y, O'Connor LM, Shepherd TG, Nachtigal MW: The p38 MAPK inhibitor, PD169316, inhibits transforming growth factor beta-induced Smad signaling in human ovarian cancer cells. Biochem Biophys Res Commun 2003;310: 391-397
54. Lazo JS, Brady LS, Dingledine R: Building a pharmacological lexicon: small molecule discovery in academia. Mol Pharmacol 2007;72:1-7
55. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73
56. Wozniak DF, Xiao M, Xu L, Yamada KA, Ornitz DM: Impaired spatial learning and defective theta burst induced ltp in mice lacking fibroblast growth factor 14.Neurobiol Dis 2007;1:14-26
57. Royeck M, Horstmann MT, Remy S, Reitze M, Yaari Y, Beck H: Role of axonal NaV1.6 sodium channels in action potential initiation of CA1 pyramidal neurons. J Neurophysiol 2008;100:2361-2380
58. Craner MJ, Newcombe J, Black JA, Hartle C, Cuzner ML, Waxman SG: Molecular changes in neurons in multiple sclerosis: altered axonal expression of Nav1.2 and Nav1.6 sodium channels and Na + /Ca2 + exchanger. Proc Natl Acad Sci USA 2004;101:8168-8173
59. Craner MJ, Hains BC, Lo AC, Black JA, Waxman SG: Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. Brain 2004;127:294-303
60. Clutterbuck LA, Posada CG, Visintin C, et al.: Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones. J Med Chem 2009;52:2694-2707
61. Madoux F, Li X, Chase P, et al.: Potent, selective and cell penetrant inhibitors of SF-1 by functional ultra-high-throughput screening. Mol Pharmacol 2008;73: 1776-1784
62. Madoux F, Simanski S, Chase P, et al.: An ultra-high throughput cell-based screen for wee1 degradation inhibitors. J Biomol Screen 2010;15:907-917
63. Rusconi R, Combi R, Cestèle S, et al.: A rescuable folding defective Nav1.1 (SCN1A) sodium channel mutant causes GEFS + : common mechanism in Nav1.1 related epilepsies? Hum Mutat 2009;30:E747-60
64. Rusconi R, Scalmani P, Cassulini RR, et al.: Modulatory proteins can rescue a trafficking defective epileptogenic Nav1.1 Na + channel mutant. J Neurosci 2007;27:11037-11046
65. Mantegazza M, Gambardella A, Rusconi R, et al.: Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. Proc Natl Acad Sci USA 2005;102:18177-18182
66. Koushika SP: ''JIP''ing along the axon: the complex roles of JIPs in axonal transport. Bioessays 2008;30:10-14
67. Gasser A, Cheng X, Gilmore ES, Tyrrell L, Waxman SG, Dib-Hajj SD: Two Nedd4- binding motifs underlie modulation of sodium channel Nav1.6 by p38 MAPK. J Biol Chem 2010;285:26149-26161
68. Stamboulian S, Choi JS, Ahn HS, et al.: ERK1/2 mitogen-activated protein kinase phosphorylates sodium channel Na(v)1.7 and alters its gating properties. J Neurosci 2010;30:1637-1647
69. Hudmon A, Choi JS, Tyrrell L, et al.: Phosphorylation of sodium channel Na(v)1.8 by p38 mitogen-activated protein kinase increases current density in dorsal root ganglion neurons. J Neurosci 2008;28:3190-3201
70. Israel A: The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol 2010;2:a000158
71. Lubin FD, Sweatt JD: The IkappaB kinase regulates chromatin structure during reconsolidation of conditioned fear memories. Neuron 2007;55:942-957
72. Boersma MC, Dresselhaus EC, De Biase LM, Mihalas AB, Bergles DE, Meffert MK: A requirement for nuclear factor-kB in developmental and plasticity-associated synaptogenesis. J Neurosci 2010;31:5414-5425
73. Sarnico I, Lanzillotta A, Benarese M, et al.: NF-kB dimers in the regulation of neuronal survival. Int Rev Neurobiol 2009;85:351-362
74. Sanchez-Ponce D, Tapia M, Munoz A, Garrido JJ: New role of IKK alpha/beta phosphorylated I kappa B alpha in axon outgrowth and axon initial segment development. Mol Cell Neurosci 2008;37:832-844
75. Sanchez-Ponce D, Munoz A, Garrido JJ: Casein kinase 2 and microtubules control axon initial segment formation. Mol Cell Neurosci 2010;46:222-234
76. Boersma MC, Meffert MK: Novel roles for the NF-kB signaling pathway in regulating neuronal function. Sci Signal 2008;1:pe7
77. Welch EM, Barton ER, Zhuo J, et al.: PTC124 targets genetic disorders caused by nonsense mutations. Nature 2007;447:87-91
78. Auld DS, Lovell S, Thorne N, et al.: Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124. Proc Natl Acad Sci USA 2010;107:4878-4883
79. Auld DS, Thorne N, Maguire WF, Inglese J: Mechanism of PTC124 activity in cellbased luciferase assays of nonsense codon suppression. Proc Natl Acad Sci USA 2009;106:3585-3590
80. Camerino DC, Desaphy JF: Grand challenge for ion channels: an underexploited resource for therapeutics. Front Pharmacol 2010;1:113
81. Tesmer JJ: Pharmacology. Hitting the hot spots of cell signaling cascades.Science 2006;312:377-378
82. Arkin MR, Wells JA: Small-molecule inhibitors of protein-protein interactions: progressing towards the dream. Nat Rev Drug Discov 2004;3:301-317
83. Brueggemann A, George M, Klau M, et al.: Ion channel drug discovery and research: the automated Nano-Patch-Clamp technology. Curr Drug Discov Technol 2004;1:91-96
84. Villalobos V, Naik S, Bruinsma M, et al.: Dual-color click beetle luciferase heteroprotein fragment complementation assays. Chem Biol 2010;17:1018-1029